Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
VMF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 4, Vitamin B
2. B 4, Vitamin
3. Vitamin B 4
1. 73-24-5
2. 1h-purin-6-amine
3. 6-aminopurine
4. 9h-purin-6-amine
5. 7h-purin-6-amine
6. Vitamin B4
7. Adenin
8. Adeninimine
9. Leuco-4
10. 6-amino-1h-purine
11. 6-amino-3h-purine
12. 6-amino-7h-purine
13. 6-amino-9h-purine
14. 1,6-dihydro-6-iminopurine
15. 3,6-dihydro-6-iminopurine
16. Purine, 6-amino-
17. Usaf Cb-18
18. 1h-purine, 6-amino
19. Adenine [jan]
20. Ade
21. 9h-purine, 1,6-dihydro-6-imino-
22. 1h-purine-6-amine
23. Ccris 2556
24. Ai3-50679
25. 3h-purin-6(7h)-imine
26. Nsc 14666
27. 9h-purine-6-amine
28. 9h-purin-6-ylamine
29. 134434-48-3
30. Chebi:16708
31. 1h-purine, 6-amino-
32. Mfcd00041790
33. Nsc-14666
34. 6h-purin-6-imine, 3,9-dihydro-, (z)- (9ci)
35. Chembl226345
36. 134434-49-4
37. 134454-76-5
38. 66224-66-6
39. Jac85a2161
40. 6h-purin-6-imine, 1,7-dihydro-, (z)- (9ci)
41. 6h-purin-6-imine, 1,9-dihydro-, (e)- (9ci)
42. 6h-purin-6-imine, 3,7-dihydro-, (z)- (9ci)
43. (z)-3,9-dihydro-6h-purin-6-imine
44. 134461-75-9
45. 71660-29-2
46. Ncgc00094856-01
47. Pedatisectine B
48. Dsstox_cid_2557
49. Dsstox_rid_76627
50. Dsstox_gsid_22557
51. Adenine-ring
52. Cas-73-24-5
53. Leucon (tn)
54. Adenine (8ci)
55. Adenine (jan/usp)
56. Adenine [usp:jan]
57. Sr-05000001754
58. 6-aminopurine (adenine)
59. Einecs 200-796-1
60. 1h-purin-6(9h)-imine
61. 1h-purin-6-amine (9ci)
62. 3h-purin-6-amine (9ci)
63. Unii-jac85a2161
64. 3h-adenine
65. 6-amino Purine
66. 6-amino-purine
67. Purin-6-amine
68. 1jys
69. 1nli
70. 1wei
71. 2pqj
72. 3kpv
73. [3h]adenine
74. Adenine, 1
75. Adenine,(s)
76. Albb-005925
77. 7h-purin-6-ylamine
78. 71660-30-5
79. (s)-norfluoxetine-d5
80. 9h-purin-6-yl-amin
81. Adenine-[15n2]
82. Spectrum_001106
83. 2p8n
84. Starbld0001134
85. 9h-purin-6-yl-amine
86. Adenine [vandf]
87. Adenine-[8-13c]
88. Specplus_000535
89. Adenine [inci]
90. Adenine, >=99%
91. 9h-purin-6-amine #
92. Adenine [mi]
93. Adenine [mart.]
94. Spectrum2_000583
95. Spectrum3_000616
96. Spectrum4_001891
97. Spectrum5_000542
98. Adenine [usp-rs]
99. Adenine [who-dd]
100. 6-aminopurine;vitamin B4
101. Bmse000060
102. Bmse000861
103. Bmse000995
104. Epitope Id:140097
105. Adenine, Cell Culture Grade
106. Schembl8110
107. Oprea1_057274
108. Us9138393, Adenine
109. Us9144538, Adenine
110. Bspbio_002152
111. Kbiogr_002447
112. Kbiogr_002562
113. Kbioss_001586
114. Kbioss_002571
115. Zinc882
116. Mls001066342
117. Divk1c_006631
118. Spectrum1500807
119. Spbio_000426
120. Adenine [ep Monograph]
121. Adenine [usp Impurity]
122. Gtpl4788
123. Adenine [usp Monograph]
124. 9h-purine,6-dihydro-6-imino-
125. Dtxsid6022557
126. Bdbm33218
127. Kbio1_001575
128. Kbio2_001586
129. Kbio2_002562
130. Kbio2_004154
131. Kbio2_005130
132. Kbio2_006722
133. Kbio2_007698
134. Kbio3_001652
135. Kbio3_003040
136. 1,9-dihydro-6h-purin-6-imine
137. Adenine 100 Microg/ml In Water
138. Cmap_000085
139. 7h-purin-6-amine, Min. 95%
140. Bcpp000433
141. Bdbm181146
142. Hms1921i14
143. Hms2092k20
144. Hms2269i04
145. Pharmakon1600-01500807
146. Bcp02865
147. Hy-b0152
148. Nsc14666
149. Vca70030
150. Tox21_111348
151. Tox21_302108
152. Bbl007925
153. Ccg-38506
154. Nsc757793
155. S1981
156. Stk387542
157. Wln: T56 Bm Dn Fn Hnj Iz
158. Akos000118903
159. Akos005171607
160. Tox21_111348_1
161. Ac-2028
162. Am83908
163. Bcp9000233
164. Cs-1984
165. Db00173
166. Nsc-757793
167. Sdccgmls-0066584.p001
168. Ncgc00094856-02
169. Ncgc00094856-03
170. Ncgc00094856-05
171. Ncgc00255120-01
172. 1217770-71-2
173. As-11841
174. Bl008313
175. Nci60_000998
176. Smr000471871
177. Adenosine Impurity A [ep Impurity]
178. Sbi-0052324.p002
179. Adenine, Vetec(tm) Reagent Grade, >=99%
180. Db-013503
181. A0149
182. Ft-0620943
183. Ft-0656198
184. 73a245
185. Adenine, Suitable For Cell Culture, Bioreagent
186. C00147
187. D00034
188. P50008
189. Q15277
190. Z-1043
191. Ab00052833-18
192. Ab00052833-19
193. Ab00052833_20
194. Ab00052833_22
195. Ab00052833_23
196. Ab00052833_24
197. A935233
198. Q-200595
199. Sr-05000001754-1
200. Sr-05000001754-2
201. W-106856
202. Adenine, Bioreagent, Plant Cell Culture Tested, >=99%
203. Adenine, European Pharmacopoeia (ep) Reference Standard
204. F0001-1848
205. Z1250132272
206. 6379c0e0-c1bb-4087-96c5-1de281b8ea4c
207. Adenine, United States Pharmacopeia (usp) Reference Standard
208. Adenine, Pharmaceutical Secondary Standard; Certified Reference Material
| Molecular Weight | 135.13 g/mol |
|---|---|
| Molecular Formula | C5H5N5 |
| XLogP3 | -0.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 0 |
| Exact Mass | 135.05449518 g/mol |
| Monoisotopic Mass | 135.05449518 g/mol |
| Topological Polar Surface Area | 80.5 Ų |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Complexity | 127 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
For nutritional supplementation, also for treating dietary shortage or imbalance
Adenine (sometimes known as vitamin B4) combines with the sugar ribose to form adenosine, which in turn can be bonded with from one to three phosphoric acid units, yielding AMP, ADP and ATP . These adenine derivatives perform important functions in cellular metabolism. Adenine is one of four nitrogenous bases utilized in the synthesis of nucleic acids. A modified form of adenosine monophosphate (cyclic AMP) is an imporant secondary messenger in the propagation of many hormonal stimuli. Adenine is an integral part of the structure of many coenzymes. Adenosine (adenine with a ribose group) causes transient heart block in the AV node of the heart. In individuals suspected of suffering from a supraventricular tachycardia (SVT), adenosine is used to help identify the rhythm. Certain SVTs can be successfully terminated with adenosine.
Adenine forms adenosine, a nucleoside, when attached to ribose, and deoxyadenosine when attached to deoxyribose, and it forms adenosine triphosphate (ATP), which drives many cellular metabolic processes by transferring chemical energy between reactions.
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Related Excipient Companies
Excipients by Applications
Parenteral
Thickeners and Stabilizers
Taste Masking
Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
11
PharmaCompass offers a list of Adenine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Adenine manufacturer or Adenine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Adenine manufacturer or Adenine supplier.
PharmaCompass also assists you with knowing the Adenine API Price utilized in the formulation of products. Adenine API Price is not always fixed or binding as the Adenine Price is obtained through a variety of data sources. The Adenine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CAS-73-24-5 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAS-73-24-5, including repackagers and relabelers. The FDA regulates CAS-73-24-5 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAS-73-24-5 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CAS-73-24-5 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CAS-73-24-5 supplier is an individual or a company that provides CAS-73-24-5 active pharmaceutical ingredient (API) or CAS-73-24-5 finished formulations upon request. The CAS-73-24-5 suppliers may include CAS-73-24-5 API manufacturers, exporters, distributors and traders.
click here to find a list of CAS-73-24-5 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CAS-73-24-5 DMF (Drug Master File) is a document detailing the whole manufacturing process of CAS-73-24-5 active pharmaceutical ingredient (API) in detail. Different forms of CAS-73-24-5 DMFs exist exist since differing nations have different regulations, such as CAS-73-24-5 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CAS-73-24-5 DMF submitted to regulatory agencies in the US is known as a USDMF. CAS-73-24-5 USDMF includes data on CAS-73-24-5's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CAS-73-24-5 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CAS-73-24-5 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The CAS-73-24-5 Drug Master File in Japan (CAS-73-24-5 JDMF) empowers CAS-73-24-5 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the CAS-73-24-5 JDMF during the approval evaluation for pharmaceutical products. At the time of CAS-73-24-5 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of CAS-73-24-5 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a CAS-73-24-5 Drug Master File in Korea (CAS-73-24-5 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of CAS-73-24-5. The MFDS reviews the CAS-73-24-5 KDMF as part of the drug registration process and uses the information provided in the CAS-73-24-5 KDMF to evaluate the safety and efficacy of the drug.
After submitting a CAS-73-24-5 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their CAS-73-24-5 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of CAS-73-24-5 suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CAS-73-24-5 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CAS-73-24-5 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CAS-73-24-5 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CAS-73-24-5 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CAS-73-24-5 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CAS-73-24-5 suppliers with NDC on PharmaCompass.
CAS-73-24-5 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CAS-73-24-5 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CAS-73-24-5 GMP manufacturer or CAS-73-24-5 GMP API supplier for your needs.
A CAS-73-24-5 CoA (Certificate of Analysis) is a formal document that attests to CAS-73-24-5's compliance with CAS-73-24-5 specifications and serves as a tool for batch-level quality control.
CAS-73-24-5 CoA mostly includes findings from lab analyses of a specific batch. For each CAS-73-24-5 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CAS-73-24-5 may be tested according to a variety of international standards, such as European Pharmacopoeia (CAS-73-24-5 EP), CAS-73-24-5 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CAS-73-24-5 USP).
